Ishizuka et al used the Glasgow Prognostic Score (GPS) to evaluate patients with Stage IV colorectal cancer. This can be used before and after surgery to predict survival. The authors are from Dokkyo Medical University n Japan.
Parameters:
(1) C-reactive protein
(2) serum albumin
Parameter |
Finding |
Points |
CRP |
<= 10 mg/L |
0 |
|
> 10 mg/L |
1 |
serum albumin |
>= 35 g/L |
0 |
|
< 35 g/L |
1 |
total score =
= SUM(points for both parameters)
Interpretation:
• minimum score: 0
• maximum score: 2
• The higher the score the greater the risk.
Additional risk factors:
(1) tumor pathology: tub1 or tub2 (well or moderately differentiated) vs other (poorly differentiated or undifferentiated)
(2) M1a (distant metastases to 1 organ) versus M1b (distant metastases to 2 or more organs)
Stage |
GPS |
50% Survival After Surgery |
M1a |
0 or 1 |
27 months |
|
2 |
7 months |
M1b |
0 |
22 months |
|
1 |
15 months |
|
2 |
10 months |
estimated from Figure 3 page 26
Specialty: Hematology Oncology, Surgery, general, Gastroenterology
ICD-10: ,